Viewing Study NCT01119066


Ignite Creation Date: 2025-12-24 @ 4:35 PM
Ignite Modification Date: 2026-07-06 @ 5:01 PM
Study NCT ID: NCT01119066
Status: COMPLETED
Last Update Posted: 2022-08-05
First Post: 2010-05-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Acute Myelogenous Leukemia View
None Myelodysplastic Syndrome View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Leukemia View
None Multiple Myeloma View
None radiation View
None Thiotepa View
None cyclophosphamide View
None fludarabine View
None Clofarabine View
None CliniMACS device View
None GCSF View
None 10-050 View